SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy’s Laboratories informs about audio recording of earnings call

24 Jan 2025 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddy’s Laboratories has informed that it enclosed the link of the audio recording of the Earnings call for the quarter ended December 31, 2024, conducted on January 23, 2025. Weblink: https://www.drreddys.com/cms/cms/sites/default/files/2025-01/10028790.mp3.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1152.00 7.65 (0.67%)
31-Jul-2026 14:26 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 2041.00
Dr. Reddys Labs. 1152.00
Cipla 1474.85
Lupin 2415.45
Zydus Lifesciences 1132.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: